Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposing

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new coronavirus discovered that appeared in Wuhan, China, in December 2019, causes COVID-19 disease which have resulted in cases similar to SARS-atypical pneumonia. Worldwide, around 116 million cases and 2.57 million deaths...

Descripción completa

Detalles Bibliográficos
Autores principales: Tristán-Flores, Fabiola E, Casique-Aguirre, Diana, Pliego-Arreaga, Raquel, Cervantes-Montelongo, Juan A, García-Gutierrez, Ponciano, Acosta-García, Gerardo, Silva-Martínez, Guillermo A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630554/
https://www.ncbi.nlm.nih.gov/pubmed/34900223
http://dx.doi.org/10.12688/f1000research.52168.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630554/
https://www.ncbi.nlm.nih.gov/pubmed/34900223
http://dx.doi.org/10.12688/f1000research.52168.2

Ejemplares similares